USPTO serial 79412458
THRPTX
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jan 6, 2026
- Examiner
- CANTONE, KERI H
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with THRPTX?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Maury M. Tepper, III
Maury M. Tepper, III Tepper & Eyster, PLLC3724 Benson DriveRaleigh, NC 27609United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable or recorded software for diagnosis, surveillance, prevention and treatment in the fields of cardiovascular, immune-inflammatory, neurodegenerative, respiratory, oncological, metabolic and osteoporosis diseases and disorders; software recorded on magnetic media or downloaded from a remote computer network for diagnosis, surveillance, prevention and treatment in the fields of cardiovascular, immune-inflammatory, neurodegenerative, respiratory, oncological, metabolic and osteoporosis diseases and disorders; downloadable computer software applications for diagnosis, surveillance, prevention and treatment in the fields of cardiovascular, immune-inflammatory, neurodegenerative, respiratory, oncological, metabolic and osteoporosis diseases and disorders; downloadable applications for mobile devices for diagnosis, surveillance, prevention and treatment in the fields of cardiovascular, immune-inflammatory, neurodegenerative, respiratory, oncological, metabolic and osteoporosis diseases and disorders | ACTIVE | — |
| 016 | Printed instructional or teaching material in the field of pharmaceuticals, pharmaceutical research and disease management; printed magazines in the field of pharmaceuticals, pharmaceutical research and disease management; printed periodicals in the field of pharmaceuticals, pharmaceutical research and disease management; printed pamphlets in the field of pharmaceuticals, pharmaceutical research and disease management | ACTIVE | — |
| 038 | Broadcasting of podcasts; transmission of podcasts; broadcasting of radio programs; broadcasting and transmission of radio programs; audio broadcasting; video broadcasting; digital audio broadcasting; radio broadcasting; dissemination being transmission of audiovisual and multimedia content via the Internet | ACTIVE | — |
| 041 | Training services in the field of pharmaceuticals, pharmaceutical research and disease management; organization and conducting of events, colloquiums, conferences, congresses, seminars or symposiums in the field of pharmaceuticals, pharmaceutical research and disease management; preparation and conducting of educational conferences and events in the field of pharmaceuticals, pharmaceutical research and disease management; organization of seminars and conferences in the field of pharmaceuticals, pharmaceutical research and disease management; multimedia publishing; podcast production | ACTIVE | — |
| 042 | Development of computer equipment and software; updating of software; programming for computers; electronic data storage; hosting of web portals; temporary provision of non-downloadable software applications accessible via a website in the field of pharmaceuticals, pharmaceutical research and disease management; internet web site design services; software development | ACTIVE | — |
| 044 | Providing advice with respect to health; information services relating to health | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by BIOFARMA
- Other trademarks owned by BIOFARMA
- Other trademarks owned by BIOFARMA
- Other trademarks in Class 009
- Other trademarks in Class 016
- Other trademarks in Class 038
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named THRPTX
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 6, 2026 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jul 16, 2026 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jul 16, 2026 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jun 4, 2026 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| May 18, 2026 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| May 18, 2026 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Apr 6, 2026 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jan 6, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jan 6, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 18, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 18, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 12, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 20, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 20, 2025 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Oct 20, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 16, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 16, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 16, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 12, 2025 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jun 23, 2025 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jun 23, 2025 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Apr 25, 2025 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Apr 24, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 8, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 20, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 19, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 18, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 27, 2024 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 27, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 19, 2024 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |